SIMI ABRAHAM: Open Payments
NPI 1912608597 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,866 in 56 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $590 · 2025 $1,866
Food & beverage: $1,786Education: $80
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $207 |
| PharmaEssentia USA Corporation | 3 | $202 |
| Incyte Corporation | 4 | $190 |
| Novartis Pharmaceuticals Corporation | 7 | $185 |
| Astellas Pharma US Inc | 4 | $174 |
| Syndax Pharmaceuticals, Inc. | 6 | $163 |
| Teleflex LLC | 1 | $154 |
| Lilly USA, LLC | 4 | $115 |
| AstraZeneca Pharmaceuticals LP | 3 | $99 |
| ABBVIE INC. | 3 | $90 |
Products named: OJJAARA, BESREMI, JAKAFI, ARROW, SCEMBLIX, JAYPIRCA, CALQUENCE, Cresemba.
Industry payments across TX — which companies pay providers there.
